SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLDX Celldex Therapeudics
CLDX 23.83-3.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche11/20/2019 11:03:16 PM
2 Recommendations

Recommended By
kimberley
Longtimeinvestor

  Read Replies (1) of 105
 
The latest project to enter the clinic. Anti-kit, a kit inhibitor. CDX-0159, pointed to chronic idiopathic urticaria.

Humanized MAb, Fc-modified to reduce potential toxicity and engineered for enhanced half-life.

clinicaltrials.gov

BTW, Marucci delivered this milestone on time.......

ir.celldex.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News